Clinical Trials Browser

Phase 3 × Head and Neck Neoplasms × Amifostine × Clear all

NCT00158691 2005-09-12

Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas

Phase 3 Completed

Head and Neck Neoplasms, Xerostomia